Review: Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease

Medications used to treat inflammatory bowel disease (IBD) have significantly improved patient outcomes and delayed time to surgery. However, some of these therapies are recognized to increase the general risk of infection and have an unclear impact on postoperative infection risk.

Read the full review here.